- Home
- CTCX vs SILO Comparison
CTCX vs SILO Comparison
Compare CTCX & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTCX
- SILO
- Stock Information
- Founded
- CTCX 2007
- SILO 2010
- Country
- CTCX United States
- SILO United States
- Employees
- CTCX N/A
- SILO N/A
- Industry
- CTCX Medical/Dental Instruments
- SILO Apparel
- Sector
- CTCX Health Care
- SILO Consumer Discretionary
- Exchange
- CTCX Nasdaq
- SILO Nasdaq
- Market Cap
- CTCX 9.4M
- SILO 8.8M
- IPO Year
- CTCX N/A
- SILO N/A
- Fundamental
- Price
- CTCX $0.24
- SILO $1.35
- Analyst Decision
- CTCX
- SILO
- Analyst Count
- CTCX 0
- SILO 0
- Target Price
- CTCX N/A
- SILO N/A
- AVG Volume (30 Days)
- CTCX 259.6K
- SILO 228.4K
- Earning Date
- CTCX 03-31-2025
- SILO 03-04-2025
- Dividend Yield
- CTCX N/A
- SILO N/A
- EPS Growth
- CTCX N/A
- SILO N/A
- EPS
- CTCX N/A
- SILO N/A
- Revenue
- CTCX $32,839.00
- SILO $72,102.00
- Revenue This Year
- CTCX N/A
- SILO $1.86
- Revenue Next Year
- CTCX N/A
- SILO N/A
- P/E Ratio
- CTCX N/A
- SILO N/A
- Revenue Growth
- CTCX N/A
- SILO N/A
- 52 Week Low
- CTCX $0.20
- SILO $0.77
- 52 Week High
- CTCX $3.35
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- CTCX 35.64
- SILO 40.14
- Support Level
- CTCX $0.23
- SILO $1.39
- Resistance Level
- CTCX $0.27
- SILO $1.52
- Average True Range (ATR)
- CTCX 0.04
- SILO 0.14
- MACD
- CTCX -0.01
- SILO -0.05
- Stochastic Oscillator
- CTCX 9.09
- SILO 0.97
About CTCX Carmell Corporation
Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.